JP2024538694A5 - - Google Patents

Info

Publication number
JP2024538694A5
JP2024538694A5 JP2024520826A JP2024520826A JP2024538694A5 JP 2024538694 A5 JP2024538694 A5 JP 2024538694A5 JP 2024520826 A JP2024520826 A JP 2024520826A JP 2024520826 A JP2024520826 A JP 2024520826A JP 2024538694 A5 JP2024538694 A5 JP 2024538694A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
haloalkyl
pharmaceutically acceptable
heteroatoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024520826A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538694A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077501 external-priority patent/WO2023060057A1/en
Publication of JP2024538694A publication Critical patent/JP2024538694A/ja
Publication of JP2024538694A5 publication Critical patent/JP2024538694A5/ja
Pending legal-status Critical Current

Links

JP2024520826A 2021-10-05 2022-10-04 シクロペンチルピラゾールcdk2阻害剤 Pending JP2024538694A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163252394P 2021-10-05 2021-10-05
US63/252,394 2021-10-05
PCT/US2022/077501 WO2023060057A1 (en) 2021-10-05 2022-10-04 Cyclopentylpyrazole cdk2 inhibitors

Publications (2)

Publication Number Publication Date
JP2024538694A JP2024538694A (ja) 2024-10-23
JP2024538694A5 true JP2024538694A5 (cg-RX-API-DMAC7.html) 2025-10-10

Family

ID=84245758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024520826A Pending JP2024538694A (ja) 2021-10-05 2022-10-04 シクロペンチルピラゾールcdk2阻害剤

Country Status (10)

Country Link
US (1) US20240425478A1 (cg-RX-API-DMAC7.html)
EP (1) EP4412995A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024538694A (cg-RX-API-DMAC7.html)
KR (1) KR20240077491A (cg-RX-API-DMAC7.html)
CN (1) CN118019734A (cg-RX-API-DMAC7.html)
AR (1) AR127247A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022360968A1 (cg-RX-API-DMAC7.html)
CA (1) CA3229067A1 (cg-RX-API-DMAC7.html)
TW (1) TW202330501A (cg-RX-API-DMAC7.html)
WO (1) WO2023060057A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3217792A1 (en) 2021-05-07 2022-11-10 Kymera Therapeutics, Inc Cdk2 degraders and uses thereof
WO2023092088A1 (en) * 2021-11-19 2023-05-25 Blueprint Medicines Corporation Cdk2 inhibitors and methods of making and using same
CA3250419A1 (en) * 2022-04-28 2025-07-08 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. CYCLOPENTANOL ESTER DERIVATIVE SUBSTITUTED BY PYRAZOLE AND ITS USE
WO2024104455A1 (zh) * 2022-11-17 2024-05-23 山东绿叶制药有限公司 Cdk2抑制剂及其制备方法和应用
WO2025136671A1 (en) * 2023-12-20 2025-06-26 Ensem Therapeutics, Inc. Anilino-pyrazole derivatives, compositions and methods thereof
WO2026024674A1 (en) 2024-07-22 2026-01-29 Genesis Therapeutics, Inc. Methods of treating skp2-associated cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3128155C (en) * 2019-01-31 2023-09-19 Pfizer Inc. 3-carbonylamino-5-cyclopentyl-1h-pyrazole compounds having inhibitory activity on cdk2
CN113766125B (zh) 2019-09-29 2022-10-25 Oppo广东移动通信有限公司 对焦方法和装置、电子设备、计算机可读存储介质
MX2023009086A (es) * 2021-02-12 2023-08-08 Relay Therapeutics Inc Inhibidores de cinasas dependientes de ciclinas (cdk) y metodos de uso de estos.

Similar Documents

Publication Publication Date Title
JP2024543975A5 (cg-RX-API-DMAC7.html)
JP2024543976A5 (cg-RX-API-DMAC7.html)
JP2023052094A5 (cg-RX-API-DMAC7.html)
JP2022544714A5 (cg-RX-API-DMAC7.html)
RU2353616C2 (ru) Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение
JP2024508755A5 (cg-RX-API-DMAC7.html)
JP2021523099A5 (cg-RX-API-DMAC7.html)
JP2023521116A5 (cg-RX-API-DMAC7.html)
JP2021522281A5 (cg-RX-API-DMAC7.html)
JP2023515618A5 (cg-RX-API-DMAC7.html)
RU2016150486A (ru) Ингибиторы бета-лактамазы
JP2019509276A5 (cg-RX-API-DMAC7.html)
JP2006515858A5 (cg-RX-API-DMAC7.html)
JP2007508305A5 (cg-RX-API-DMAC7.html)
JP2017214387A5 (cg-RX-API-DMAC7.html)
JP2017504595A5 (cg-RX-API-DMAC7.html)
JP2020527175A5 (cg-RX-API-DMAC7.html)
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
JP2022533939A5 (cg-RX-API-DMAC7.html)
JP2018510202A5 (cg-RX-API-DMAC7.html)
JP2022501334A5 (cg-RX-API-DMAC7.html)
JP2021535213A5 (cg-RX-API-DMAC7.html)
JP2020511547A5 (cg-RX-API-DMAC7.html)
JP2023553428A5 (cg-RX-API-DMAC7.html)
JP2022508642A5 (cg-RX-API-DMAC7.html)